Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Prostate cancer diagnosis may get easier with liquid biopsy

NCT ID NCT05141383

First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 27 times

Summary

This completed study looked at whether urine and blood samples can be used to find biomarkers for prostate cancer. Researchers collected samples from 80 men, including those with prostate cancer, those with suspected cancer, and healthy donors. The goal was to see if these liquid biopsies could help diagnose and monitor prostate cancer without the need for traditional tissue biopsies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Institut Curie

    Paris, 75005, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to a simple urine or blood test to diagnose prostate cancer and monitor it without needing invasive biopsies.

What could go wrong

This is an early-stage study focused on collecting samples and testing methods, not yet proving the test works in practice. The results may not translate into a reliable clinical test.

Conditions

The condition(s) this trial relates to.

benign prostatic hyperplasia disease prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.